Fleet Bioprocessing to Attend EBF 11th Open Symposium, Barcelona

Fleet Bioprocessing has announced that it will be attending the European Bioanalytical Forum (EBF) 11th Open Symposium.

Taking place from 21–23 November, EBF aims to bring companies together to implement a platform for discussions of science, day-to-day procedures, business tools, technologies and regulatory issues.

Fleet Bioprocessing will be offering expertise in the development, validation and manufacture of bioconjugates. It also possesses industry-leading expertise in all aspects of immunoassay design, development and validation and is a certified assay transfer and development partner for the Gyrolab high-throughput immunoassay platform.

If you would like to discuss any aspect of bioconjugation, enzyme-linked immunosorbent assay (ELISA) development or Gyrolab assay development, please contact Fleet Bioprocessing using the contact form on this page.

More About This Company